In Thailand, stem cell therapy for ALS typically costs between AUD $34,719 / ฿A1,180,456 and AUD $62,495 / ฿A2,124,820. Final pricing depends on the cell count, infusion method, and laboratory standards. Patients often save approximately 17% compared to average Australian costs of AUD $42,080 / ฿A1,430,712. Standard bundles often cover specialist consultations, lab testing, cell administration, and airport transfers.
Bookimed Expert Insight: Thai clinics provide high-level assurance through partnerships with government-led scientific bodies. For example, EDNA Wellness in Bangkok operates under OECD GLP standards and partners with the Thailand Institute of Scientific and Technological Research. This link to national research institutions offers Australians a level of oversight often missing in other medical tourism hubs. Choosing clinics with ISO 9001:2015 certification helps ensure the laboratory processes meet global quality requirements.
| Thailand | Turkey | ||
| Stem cell therapy for ALS (amyotrophic lateral sclerosis) | from AUD $34,719 / ฿A1,180,456 | from AUD $41,663 / ฿A1,416,547 | from AUD $11,805 / ฿A401,355 |
Dr Chollawat Thongthaisin is the Lead Doctor at Vega Stem Cell and a diplomate of the American Board of Regenerative Medicine.
Dr. Ekkaparb Charoensuk (Doctor Neung) is a physician in integrative, regenerative, and preventive medicine. He has over 15 years of experience in clinical care, preventive health, and regenerative therapies. He serves on the clinic’s medical team. He supports dermatology procedures, aesthetic treatments, and regenerative care.
Accreditations include: MD (Mahidol University); Mini Master of Management in Health (Public Health), ASEAN Institute for Health Development; Medical Doctor License, Medical Council of Thailand. He also holds a Board Diploma in Anti-Aging Medicine (WOSAAM) and a Certification in Public Health & Preventive Medicine from the Preventive Medicine Association of Thailand.
Clinical focus: integrative and regenerative medicine; preventive medicine and health optimisation; injection-based and procedural therapies; skin rejuvenation and aesthetic treatments. He provides patient-centred, multidisciplinary care.
Dr. Pongsathron Liengwattanakol, M.D., is an orthopedic surgeon at Mali Interdisciplinary Hospital in Bangkok. He earned his M.D. from Thammasat University (2007–2013). He completed his orthopedic surgery residency at Thammasat University (2016–2021). He previously served as a general practitioner and orthopedic officer at Buddhasothorn Hospital. He also worked as an orthopedic surgeon at Asia International Hospital.
Accreditations include board certification in Longevity and Quality of Life Medicine and in Nutritional Wellness. He holds diplomas in Clinical Sexology and Sexual Medicine. He also holds a Sex Therapy certificate. He is certified in Advanced Cardiac Life Support (ACLS).
Advanced training includes Recent Advances in Regenerative Medicine (2025). He trained in advanced hyaluronic acid injection. He has experience with mesotherapy, vitamin therapy, and PRP. He completed courses in multidisciplinary botulinum toxin use and regenerative cosmetic dermatology. He trained in FUE hair transplant and non‑invasive intimacy fillers (2024). He also studied pain and insomnia management.
Dr. Gerald Raphael Tur is an osteopath and regenerative medicine specialist at Vega Clinic in Bangkok. He serves as the official Phuket representative for the Osteopathy Chronic Pain Clinics of Canada. Dr. Tur is certified by the Union of Thai Traditional Medicine Society. He also holds acupuncture certification from the Chinese Republic.
Stem cell therapy for ALS in Thailand is an experimental treatment. It is not a standard medical protocol. Private clinics in Bangkok provide these therapies. However, they remain outside conventional medical channels. Safety is generally high in ISO-certified facilities. These clinics use mesenchymal stem cells to minimise rejection risks.
Bookimed Expert Insight: Many countries lack clear pathways for these treatments. Thailand allows private clinics to offer them under strict laboratory standards. Verification is key. Facilities with ISO/IEC 17025:2017 accreditation offer reliable quality control for Australians seeking experimental options.
Patient Consensus: Treatment in Thailand is seen as an experimental step. It requires deep research into clinical protocols. Patients suggest choosing centres with transparent follow-up plans. They also recommend looking for documented results from previous cases.
Stem cell therapy for ALS in Thailand uses mesenchymal stem cells (MSCs) to slow disease progression. These treatments aim to improve quality of life. Specialists use intravenous or intrathecal injections to reduce inflammation and support motor neurons. Treatment typically occurs in JCI or ISO-accredited clinics in Bangkok.
Bookimed Expert Insight: Many clinics offer general stem cell treatments. However, the most reliable outcomes for neurological conditions in Thailand come from centres partnering with TISTR. These partnerships help laboratory-grown cells meet strict OECD Good Laboratory Practice standards.
Patient Consensus: Patients suggest asking for exact cell dosages. They also advise separating the benefits of bundled intensive physiotherapy from the stem cell results. They recommend coordinating with a local neurologist before travelling to Thailand for a cohesive care plan.
Patients should expect stem cell therapy for ALS in Thailand to function as a supportive treatment rather than a cure. The procedure aims to slow disease progression and improve quality of life. Realistically, outcomes include stabilised motor function, improved facial muscle strength, and temporary gains in breathing capacity.
Bookimed Expert Insight: The primary goal is slowing progression. Thailand stands out because doctors like Dr Chollawat Thongthaisin hold American Board of Regenerative Medicine certification. This helps patients follow international protocols. However, treatments in Thailand cost between $25,000 and $45,000. This is higher than the $30,300 Australian average. The premium pays for laboratory partnerships and board-certified specialists.
Patient Consensus: Patients in Thailand report that while recovery is not the reality, the treatment can offer modest slowing of the disease. They suggest prioritising rest. Both the travel and procedure are physically taxing for individuals with ALS.
Several Bangkok medical facilities specialise in stem cell therapy for ALS. These centres focus on regenerative medicine to support neurological function. EDNA Wellness and Vega Clinic are notable for their lab partnerships and board-certified experts. They provide tailored mesenchymal stem cell protocols within internationally recognised safety frameworks.
Bookimed Expert Insight: While mainstream hospitals cost upwards of $45,000, labs partnering with EDNA Wellness provide same-day processing. This direct lab-to-clinic pathway maintains higher cell viability. This is critical for patients travelling from Australia.
Patient Consensus: Patients in Bangkok often use protocols involving both local injections and intranasal administration. This allows for better neural access. Many recommend requesting peer-reviewed data and exact cell counts before starting any regenerative therapy program.